Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
2019 / 06 Vol. 46; Iss. s1
![](/img/cover-not-exists.png)
P.063 SUNFISH Part 1 results and Part 2 trial design in patients with type 2/3 spinal muscular atrophy (SMA) receiving risdiplam (RG7916)
Campbell, C, Mercuri, E, Baranello, G, Kirschner, J, Servais, L, Goemans, N, Pera, M, Buchbjerg, J, Yeung, W, Kletzl, H, Gerber, M, Czech, C, Cleary, Y, Gorni, K, Khwaja, OVolume:
46
Journal:
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
DOI:
10.1017/cjn.2019.163
Date:
June, 2019
File:
PDF, 2.05 MB
2019